McDonnell Boehnen Hulbert & Berghoff LLP (JD Supra India)
The Anatomy of a Compulsory License: Natco Pharma Ltd. v. Bayer Corp. (Indian Patent Office)
In response to an earlier post on Novartis' challenge to the Indian Patent Office's decision not to grant a patent on its anticancer drug Gleevec® (see "Indian Supreme Court to Rule on Gleevec Patent"), a reader opined that we should appreciate the erudition and wisdom of the patent official in Mumbai responsible for the denial. He helpfully sent along the decision granting a compulsory license...
Indian Supreme Court to Rule on Gleevec Patent
One of the signal achievements of late 20th Century trade diplomacy was the ratification of the Uruguay Round of the General Agreement on Tariffs and Trade (GATT), and specifically the Trade-related Aspects on Intellectual Property Rights (TRIPS). These international agreements created the World Trade Organization and changed national practices regarding intellectual property rights protection,...